Helix Nanotechnologies: The mRNA Platform That Bet Early on Cancer, COVID-19, and Climate Change
The story of Helix Nanotechnologies (Y Combinator W17), a Boston-based mRNA startup founded by Nikolai Eroshenko, which bet on mRNA technology back in 2017 — years before COVID-19 mRNA vaccines changed the world.
Think & Rich